Can Insurers Curb Opioid Abuse? CDC Puts Spotlight On Payers
This article was originally published in The Pink Sheet Daily
As Medicare emerges as the dominant payer for opioids, CDC urges research into how government and private payers could best employ prior authorization and drug utilization reviews.
You may also be interested in...
Consumers with chronic pain spend less in co-pays for pain medications than they would for natural remedies or treatments such as chiropractic or acupuncture because few insurance plans pay for alternative care, NIH advisory committee members say.
Our infographic illustrates the recommendations in FDA’s COVID-19 pandemic recovery and preparedness plan, ranging from strengthening the EUA process to managing the backlog of pending inspections.
Operation Warp Speed confirmed the necessity of having a facility on hand to develop and manufacture a vaccine for the next crisis, the outgoing advisor says.